Want to see NL:AKZA full AI Analyst Report?
Akzo Nobel NV (AKZA) AI Stock Analysis
Top Page
Akzo Nobel NV
(Amsterdam:AKZA)
The score is driven primarily by stable-to-improving profitability and positive cash generation, tempered by declining revenue and rising leverage. Technicals are supportive with price above major moving averages and positive MACD, while valuation is reasonable with a moderate P/E and a solid dividend yield.
Akzo Nobel NV (AKZA) vs. iShares MSCI Netherlands ETF (EWN)
- Market Cap
- EUR 10.17B
- Dividend Yield
- 3.34%
- Average Volume (3M)
- 495.84K
- Price to Earnings (P/E)
- 15.6
- Beta (1Y)
- 1.01
- Revenue Growth
- -5.00%
- EPS Growth
- 1020.46%
- Country
- Netherlands
- Employees
- 29,900
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Akzo Nobel NV Business Overview & Revenue Model
Company Description
Akzo Nobel N.V. operates globally as a prominent manufacturer and distributor of paints and protective coatings. The company provides a comprehensive selection of decorative solutions, including paints, lacquers, and varnishes, alongside advanced mix...
How the Company Makes Money
AkzoNobel primarily makes money by selling coating products—both decorative paints and industrial/performance coatings—to professional customers and distribution partners worldwide. Its revenue model is predominantly product sales: it manufactures co...
Akzo Nobel NV Financial Statement Overview
Summary
Profitability is solid with improved operating margin in TTM, and earnings plus free cash flow remain positive. Offsetting this, revenue is trending down and leverage has risen (higher debt-to-equity), while free cash flow has been volatile and lighter versus revenue.
Income Statement
70PositiveBalance Sheet
56NeutralCash Flow
62Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.88B | 10.16B | 10.71B | 10.67B | 10.85B | 9.59B |
| Gross Profit | 4.02B | 4.05B | 4.34B | 4.23B | 3.92B | 3.85B |
| EBITDA | 2.27B | 1.54B | 1.40B | 1.41B | 1.06B | 1.53B |
| Net Income | 652.00M | 635.00M | 542.00M | 442.00M | 352.00M | 829.00M |
Balance Sheet | ||||||
| Total Assets | 16.02B | 13.95B | 14.25B | 14.56B | 14.74B | 13.88B |
| Cash, Cash Equivalents and Short-Term Investments | 3.41B | 1.92B | 1.47B | 1.78B | 1.79B | 1.21B |
| Total Debt | 6.50B | 4.86B | 5.37B | 5.56B | 5.88B | 3.55B |
| Total Liabilities | 11.00B | 9.13B | 9.43B | 10.01B | 10.19B | 8.24B |
| Stockholders Equity | 4.85B | 4.66B | 4.57B | 4.32B | 4.33B | 5.42B |
Cash Flow | ||||||
| Free Cash Flow | 500.00M | 606.00M | 362.00M | 834.00M | -29.00M | 317.00M |
| Operating Cash Flow | 799.00M | 915.00M | 741.00M | 1.21B | 291.00M | 605.00M |
| Investing Cash Flow | 319.00M | 424.00M | -132.00M | -144.00M | -1.09B | -134.00M |
| Financing Cash Flow | 680.00M | -964.00M | -684.00M | -827.00M | 1.14B | -974.00M |
Akzo Nobel NV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AKZA, the sentiment is Positive. The current price of 59.30 is above the 20-day moving average (MA) of 58.40, above the 50-day MA of 58.25, and above the 200-day MA of 56.02, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 55.56 is Neutral, neither overbought nor oversold. The STOCH value of 54.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:AKZA.
Akzo Nobel NV Peers Comparison
Overall Rating
NL:CRBN68Neutral
NL:DSFIR67Neutral- NL:AKZA66Neutral
NL:IMCD62Neutral
NL:AALB61Neutral
NL:HOLCO59Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| NL:CRBN | 68Neutral | EUR 1.58B | 25.35 | 8.30% | 2.34% | -3.37% | -8.22% |
| NL:DSFIR | 67Neutral | EUR 25.56B | -22.15 | ― | 2.34% | -44.75% | -301.20% |
| NL:AKZA | 66Neutral | EUR 10.17B | 15.56 | 13.55% | 3.34% | -5.00% | 1020.46% |
| NL:IMCD | 62Neutral | EUR 6.03B | 26.22 | 11.06% | 1.77% | 2.64% | -14.83% |
| NL:AALB | 61Neutral | EUR 4.45B | 29.44 | 6.21% | 2.79% | 0.24% | 2.12% |
| NL:HOLCO | 59Neutral | EUR 61.95M | 17.78 | 5.86% | 2.81% | -4.36% | -25.90% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NL:AKZA | Akzo Nobel NV | 59.30 | 4.54 | 8.29% | |
| NL:AALB | Aalberts Industries N.V. | 41.22 | 14.87 | 56.46% | |
| NL:CRBN | Corbion NV | 27.38 | 10.63 | 63.50% | |
| NL:HOLCO | Holland Colours N.V. | 72.00 | -19.66 | -21.44% | |
| NL:IMCD | IMCD N.V. | 102.25 | 15.92 | 18.44% | |
| NL:DSFIR | DSM-Firmenich AG | 106.75 | 39.56 | 58.89% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026